| 000 | 00636nam a22001697a 4500 | ||
|---|---|---|---|
| 003 | OSt | ||
| 005 | 20260406112641.0 | ||
| 008 | 260406b |||||||| |||| 00| 0 eng d | ||
| 040 | _cMRSPTU | ||
| 041 | _aEnglish | ||
| 100 | _aSourav Kalsi, Supervisor: Dr. Navjot Kanwar | ||
| 245 | _a Assessing Adverse Events Following Immunization: Pharmacovigilance Study on the Safety of Covaxin in Preventing Covid-19 Breakthrough Infections | ||
| 260 |
_bDepartment of Pharmacy, MRSPTU, Bathinda _c2024 |
||
| 650 | _aPharmaceutical Sciences and Technology | ||
| 856 | _uhttp://163.47.215.52:8080/jspui/handle/123456789/872 | ||
| 942 |
_2ddc _cTH _n0 |
||
| 999 |
_c11286 _d11286 |
||